Good levels to buy TRVN

17 нояб. 2020 г.

Very bullish for NASDAQ:TRVN in the long term.
- High demand product with blockbuster drug good for opiod crisis.
- Potential replacement for morphine, no real competitor
- Partnership with Syneos for sales
- Potential buyout

Good levels to buy at 2.50 and 2.33

Should see rise towards next quarter earnings.

Long term PTs
TP1 - $5
TP2 - $15
TP3 - $30

8 дек. 2020 г.

Заметка

hold

27 дек. 2020 г.

Заметка

Falling wedge pattern in the short term and an ascending triangle on the mid term.

Continue hold towards next quarter earnings in March

6 янв. 2021 г.

Сделка активна

finance.yahoo.com/news/trevena-inc-provides-commercial-launch-120000483.html

7 янв. 2021 г.

Заметка

Seems to breaking out of the falling wedge